Alkeus Pharmaceuticals
PrivateLast Round
Series B
Jun 5, 2023
Total Funding Raised
$158.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alkeus Pharmaceuticals is a biopharmaceutical company that develops innovative therapies for serious and untreatable eye diseases, including Stargardt disease and geographic atrophy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alkeus Pharmaceuticals Comparables
Compare Alkeus Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascidian Therapeutics | 86% | |
| City Therapeutics | 84% | |
| Atsena Therapeutics | 84% | |
Alkeus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 5, 2023 | ||||
| Grant | Sep 26, 2018 | ||||
| Grant | Oct 22, 2013 | ||||
| Accelerator | Oct 1, 2010 |
Key People
Founding team and executive leadership
Alkeus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series B |
| TCG Crossover | Series B |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| MassChallenge Israel | Accelerator |
| Wellington Management | Series B |
| Food and Drug Administration | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Lead compound ALK-001 granted breakthrough therapy and orphan drug status.
- Feb 25, 2026
Presenting data at the 49th Annual Meeting of the Macula Society.
Alkeus Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alkeus Pharmaceuticals's valuation, stock price, and market status.